(Q39109834)

9 September 2017

title

ΔNp63 expression in four carcinoma cell lines and the effect on radioresistance--a siRNA knockdown model (English)

1 reference

9 September 2017

Maximilian Moergel

1

1 reference

9 September 2017

Jutta Goldschmitt

series ordinal

2

1 reference

9 September 2017

Marcus Stockinger

series ordinal

3

1 reference

9 September 2017

Martin Kunkel

series ordinal

4

1 reference

9 September 2017

publication date

15 August 2013

1 reference

Clinical Oral Investigations

9 September 2017

published in

1 reference

9 September 2017

volume

18

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

1259-1268

1 reference

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Identification and functional characterization of two new transcriptional variants of the human p63 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

p63 is a p53 homologue required for limb and epidermal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Immunohistochemical demonstration of p63 in DMBA-induced hamster buccal pouch squamous cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Differential expression of p63 isoforms in normal tissues and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Genetic imbalances with impact on survival in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

p63, a story of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Dominant negative p63 isoform expression in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

IGF1 activates cell cycle arrest following irradiation by reducing binding of ΔNp63 to the p21 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-013-1078-0

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck

21 January 2018

1 reference

12 December 2020

Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.

1 reference

12 December 2020

Expression Profile of p63 in 127 Patients with Laryngeal Squamous Cell Carcinoma

1 reference

12 December 2020

Primer3 on the WWW for general users and for biologist programmers

1 reference

12 December 2020

Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.

1 reference

12 December 2020

10.1007/S00784-013-1078-0

Identifiers

DOI

1 reference

9 September 2017

1 reference